I MUST start by confessing that I have no new discoveries to lay before this meeting and that my paper is really an effort at propaganda, for I desire to enlist your help in clearing up a remarkably unsatisfactory situation. The position is that the laboratory workers, that is to say, the chemists and pharmacologists, agree that ergot contains certain specific active alkaloids, and they believe that these are the substances upon which its therapeutic value in obstetrics depends, but they also agree that the preparations of ergot described in the British Pharmacopoeia cannot contain more than traces of these active alkaloids, and hence they conclude that these said preparations must be almost completely inert.
On the other hand, these B. P. preparations have been used for at least thirty years without complaint by clinicians. Since a new pharmacopoeia is likely to be prepared in the near future, it is obviously of public interest that this uncertainty should be settled. This can only be done by co-operation between laboratory and clinical workers. I propose to-night to set before you the evidence in favour of the beliefs held by the laboratory workers, and I trust that you will criticise these in the light of your clinical experience of the drug.
The very powerful and curious toxic actions of ergot have been known only too well since prehistoric times, since epidemics due to the eating of ergotised rye have repeatedly produced widespread poisoning in Europe. The 
